1. Medical Cost to Treat Cervical Cancer Patients at a Social Security Third Level Oncology Hospital in Mexico City
- Author
-
Granados-García, Víctor, Piña-Sánchez, Patricia, Reynoso-Noveron, Nancy, Flores, Yvonne N, Toledano-Toledano, Filiberto, Estrada-Gómez, Gloria, Apresa-García, Teresa, and Briseño, Arely A
- Subjects
Health Services and Systems ,Biomedical and Clinical Sciences ,Health Sciences ,Clinical Research ,Prevention ,Behavioral and Social Science ,Health Services ,Cancer ,Basic Behavioral and Social Science ,Good Health and Well Being ,Female ,Health Care Costs ,Hospitals ,Humans ,Medical Oncology ,Mexico ,Middle Aged ,Retrospective Studies ,Social Security ,Uterine Cervical Neoplasms ,Treatment costs ,cost analysis ,cervical cancer ,Clinical Sciences ,Oncology and Carcinogenesis ,Public Health and Health Services ,Oncology & Carcinogenesis ,Oncology and carcinogenesis ,Epidemiology ,Public health - Abstract
Background: Cervical Cancer (CC) is an important public health problem worldwide. In 2015, CC was the sixthleading cause of death for women aged 30-59 years in Mexico. Despite the importance of having high-quality andaccurate estimates of CC treatment costs that can be used to effectively evaluate the impact of preventive programs, thereis scarce information on this topic in Mexico. Objective: To estimate the treatment costs by stage diagnosis in patientswith CC at a Mexican Social Security Institute (IMSS) oncology hospital in Mexico City. Methods: An observationalretrospective study of the resources used to treat 346 women with CC was conducted. Medical charts were reviewed andrelevant resource use information was extracted using a data collection instrument that was created based on treatmentguidelines. Data were classified into nine cost categories to estimate the total cost per patient. Results: The mean ageof patients in the study sample was 54.3 years (range: 41-67), and the average body mass index (BMI) was >26 kg/m2.Among the participants, 37% were smokers, 39% had diabetes, and 56% had hypertension. The medical cost for stagesI-IV ranged from $4,738 to $6,058 USD, with an estimated average cost of $5,114 USD. Conclusion: Total treatmentcosts per patient are high, especially since they were estimated considering only 7.5 months of treatment. This is thefirst study to estimate the annual cost to treat CC in Mexico and to additionally document the resource pattern use, costby stage of cancer, and the distribution by cost categories.
- Published
- 2019